ArticleTranslational lung cancer research2019

Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).

Hiren Mandaliya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.